Cegedim Dendrite: 77% Of European Bio-Pharmaceutical Companies See the Economic Situation as One of the Key Challenges Affecting Market Access Strategies

PARIS--(BUSINESS WIRE)--Cegedim Dendrite (Paris:CGM), the leading provider of CRM software and healthcare data to the bio-pharmaceutical industry, today announces the results of The Cegedim Dendrite Market Access Industry Report 2010; a market research survey conducted in May this year across nearly 200 European executives from marketing, market access, market research and sales departments within bio-pharmaceutical organisations.